EVI5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.095400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.092000E-01
Normal-vs-Stage2
6.967800E-01
Normal-vs-Stage3
1.667170E-01
Normal-vs-Stage4
7.336000E-01
Stage1-vs-Stage2
8.572600E-01
Stage1-vs-Stage3
2.567800E-01
Stage1-vs-Stage4
3.813000E-01
Stage2-vs-Stage3
1.923590E-01
Stage2-vs-Stage4
2.837600E-01
Stage3-vs-Stage4
1.604190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.286000E-01
Normal-vs-AfricanAmerican
7.173800E-01
Normal-vs-Asian
3.741000E-01
Caucasian-vs-AfricanAmerican
3.826000E-01
Caucasian-vs-Asian
3.643200E-01
AfricanAmerican-vs-Asian
1.542390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.308200E-01
Normal-vs-Female
8.195000E-01
Male-vs-Female
2.349400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.040200E-01
Normal-vs-Age(41-60Yrs)
8.258600E-01
Normal-vs-Age(61-80Yrs)
5.516000E-01
Normal-vs-Age(81-100Yrs)
1.556450E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.377600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.178800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.273000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.156000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.781900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.330400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.658600E-01
Normal-vs-Daily Drinker
2.849400E-01
Normal-vs-Weekly Drinker
5.071200E-01
Normal-vs-Occasional Drinker
9.160200E-01
Normal-vs-Social Drinker
8.757600E-01
Non Drinker-vs-Daily Drinker
6.430400E-01
Non Drinker-vs-Weekly Drinker
5.045000E-01
Non Drinker-vs-Occasional Drinker
7.987800E-02
Non Drinker-vs-Social Drinker
1.058250E-01
Daily Drinker-vs-Weekly Drinker
3.681400E-01
Daily Drinker-vs-Occasional Drinker
4.857600E-02
Daily Drinker-vs-Social Drinker
5.352500E-02
Weekly Drinker-vs-Occasional Drinker
2.747400E-01
Weekly Drinker-vs-Social Drinker
2.650200E-01
Occasional Drinker-vs-Social Drinker
9.115200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.346400E-01
Normal-vs-Grade 2
1.096630E-01
Normal-vs-Grade 3
2.209400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.063000E-01
Grade 1-vs-Grade 3
4.678400E-01
Grade 1-vs-Grade 4
3.346400E-01
Grade 2-vs-Grade 3
6.968600E-01
Grade 2-vs-Grade 4
1.096630E-01
Grade 3-vs-Grade 4
2.209400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.766400E-01
Normal-vs-NonDiabetic
6.502400E-01
Diabetic-vs-NonDiabetic
2.697200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.947000E-01
Normal-vs-NoPancreatitis
6.639000E-01
Pancreatitis-vs-NoPancreatitis
3.649600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.306200E-01
Normal-vs-N1
7.147000E-01
N0-vs-N1
7.621800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.960600E-01
Normal-vs-TP53-NonMutant
7.722000E-01
TP53-Mutant-vs-TP53-NonMutant
6.396200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
